An Observational Study of Octreotide Subcutaneous Depot in Patients With Acromegaly
A Multi-Center, Multinational, Observational Study of Octreotide Subcutaneous Depot for the Treatment of Patients With Acromegaly
- Acromegaly
At a glance
- Phase
- Phase not stated
- Study type
- Observational
- Sponsor
- Camurus AB
- Enrolment target
- 200
- Started
- 5 June 2026
- Main results due
- June 2029
- Study sites
- 6
- Registry updated
- 25 September 2026
Can you take part?
- Aged 18 years and over.
- Open to any sex.
- You need the condition being studied — healthy volunteers are not accepted.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion Criteria: * Have started or will be starting treatment with octreotide SC depot for acromegaly Exclusion Criteria: * Have started or will be starting treatment with octreotide SC depot for other conditions not related to acromegaly * Currently taking part in an interventional clinical trial or is still within a 30-day washout period from the end of taking part in an interventional clinical trial.
What this study is about
In the sponsor’s own words, from the registry.
The purpose of this study is to collect long-term (up to two years) safety and effectiveness of octreotide subcutaneous depot in patients with acromegaly in the real-world setting.
Study sites(6)
Universitaetsklinikum Aachen
Aachen, Germany
Recruiting
Universitaetsklinikum Leipzig
Leipzig, Germany
Recruiting
Fachpraxis für Innere Medizin, Endokrinologie und Diabetologie
Magdeburg, Germany
Recruiting
Medicover Neuroendokrinologie MVZ
München, Germany
Not yet recruiting
Universitätsklinikum Würzburg
Würzburg, Germany
Recruiting
St James's University Hospital - Leeds Teaching Hospitals NHS Trust
Leeds, United Kingdom
Not yet recruiting
Showing 6 of 6 sites. 4 of the 6 sites on this study are recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT07583563. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me